GB201520862D0 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- GB201520862D0 GB201520862D0 GBGB1520862.2A GB201520862A GB201520862D0 GB 201520862 D0 GB201520862 D0 GB 201520862D0 GB 201520862 A GB201520862 A GB 201520862A GB 201520862 D0 GB201520862 D0 GB 201520862D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1520862.2A GB201520862D0 (en) | 2015-11-25 | 2015-11-25 | Pharmaceutical composition |
PCT/EP2016/078564 WO2017089404A1 (en) | 2015-11-25 | 2016-11-23 | Pharmaceutical composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1520862.2A GB201520862D0 (en) | 2015-11-25 | 2015-11-25 | Pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201520862D0 true GB201520862D0 (en) | 2016-01-13 |
Family
ID=55177258
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1520862.2A Ceased GB201520862D0 (en) | 2015-11-25 | 2015-11-25 | Pharmaceutical composition |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201520862D0 (en) |
WO (1) | WO2017089404A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020031148A1 (en) * | 2018-08-10 | 2020-02-13 | Tykhonivska Nataliya | Pharmaceutical composition, medicinal product and method of treatment of bronchopulmonary obstructive diseases |
WO2020084549A1 (en) * | 2018-10-25 | 2020-04-30 | Glenmark Specialty S.A. | Nebulization composition comprising glycopyrrolate and formoterol |
CA3186956A1 (en) * | 2020-07-31 | 2022-02-03 | Chemo Research , S.L. | Combination therapy for inhalation administration |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013203244B2 (en) * | 2009-10-16 | 2016-11-03 | Jagotec Ag | Improved formulations |
CN103501776A (en) * | 2011-02-17 | 2014-01-08 | 西普拉有限公司 | Composition of glycopyrrolate and a beta2-agonist |
CA2898682A1 (en) * | 2013-01-31 | 2014-08-07 | Prosonix Limited | Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy |
MY176191A (en) * | 2013-12-30 | 2020-07-24 | Chiesi Farm Spa | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination |
-
2015
- 2015-11-25 GB GBGB1520862.2A patent/GB201520862D0/en not_active Ceased
-
2016
- 2016-11-23 WO PCT/EP2016/078564 patent/WO2017089404A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2017089404A1 (en) | 2017-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL265360A (en) | Pharmaceutical composition | |
IL265260B (en) | Pharmaceutical composition | |
GB201409471D0 (en) | Pharmaceutical composition | |
IL262654A (en) | Pharmaceutical composition | |
IL265349A (en) | Pharmaceutical composition | |
GB201409488D0 (en) | Pharmaceutical composition | |
GB201409485D0 (en) | Pharmaceutical composition | |
SI3278801T1 (en) | Pharmaceutical composition containing mirabegron | |
GB201506526D0 (en) | Medicinal composition | |
IL263040A (en) | Pharmaceutical composition comprising eteplirsen | |
GB201521462D0 (en) | Pharmaceutical composition | |
GB201515310D0 (en) | Pharmaceutical composition | |
HK1245073A1 (en) | Pharmaceutical compositions | |
PL3454838T3 (en) | Pharmaceutical composition | |
GB201615917D0 (en) | Pharmaceutical composition | |
GB201520862D0 (en) | Pharmaceutical composition | |
GB201615914D0 (en) | Pharmaceutical composition | |
GB201615910D0 (en) | Pharmaceutical composition | |
PL3089740T3 (en) | Pharmaceutical composition | |
IL265436B (en) | Pharmaceutical composition | |
PL3424500T3 (en) | Pharmaceutical composition comprising famitinib | |
GB2529605B (en) | Pharmaceutical composition | |
IL265428A (en) | Pharmaceutical composition | |
PT3476391T (en) | Pharmaceutical composition | |
GB201620513D0 (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |